S2Medical AB (OSTO:S2M) ROCE % : 81.18% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is S2Medical AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. S2Medical AB's annualized ROCE % for the quarter that ended in Mar. 2024 was 81.18%.

S2Medical AB ROCE % Historical Data

The historical data trend for S2Medical AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

S2Medical AB ROCE % Chart

S2Medical AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

-38.41

-51.62

-50.95

-82.89

-254.61

S2Medical AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
ROCE %	Get a 7-Day Free Trial															-353.97	-391.41	-223.33	-106.87	81.18

S2Medical AB ROCE % Calculation

S2Medical AB's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-27.689	/	( ( (29.676 - 14.995)	+	(25.294 - 18.225) )	/ 2 )
	=	-27.689	/	( (14.681	+	7.069)	/ 2 )
	=	-27.689	/	10.875
	=	-254.61 %

S2Medical AB's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Sep. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Sep. 2023 )		(Q: Mar. 2024 )
	=	3.224	/	( ( (23.612 - 18.131)	+	(21.819 - 19.357) )	/ 2 )
	=	3.224	/	( ( 5.481	+	2.462 )	/ 2 )
	=	3.224	/	3.9715
	=	81.18 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

S2Medical AB (OSTO:S2M) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

S2Medical AB ROCE % Related Terms

Thank you for viewing the detailed overview of S2Medical AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

S2Medical AB (OSTO:S2M) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » S2Medical AB (OSTO:S2M) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

S21:Germany

Address

Sunnorpsgatan 5, Linkoping, SWE, 582 73

Website

https://www.s2m.se

S2Medical AB is a research-intensive MedTech company from Sweden. The company has developed several unique wound care products and has many disruptive technologies in the pipeline. Its products include wound debridment, blood stilling, skin grafting, tissue substitutes, bandage, and antimicrobial.

S2Medical AB (OSTO:S2M) Headlines

No Headlines